We serve 2-(7-Methoxynaphthalen-1-yl)Acetic Acid CAS:6836-22-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: 2-(7-Methoxynaphthalen-1-yl)Acetic Acid
CAS.NO:6836-22-2
Synonyms:
2-(7-Methoxynaphthalen-1-yl)acetic acid
Molecular Formula: C13H12O3
Molecular Weight: 216.23300
Physical and Chemical Properties:
Density: 1.235
Boiling point: 408.8ºC at 760 mmHg
Melting point: 153-154ºC
Flash point: 160.7ºC
Refractive index: 1.625
Specification:
Appearance: Light yellow powder
Purity:≥99%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage: Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:
Intermediates of Agomelatine CAS:138112-76-2
Contact us for information like 2-(7-Methoxynaphthalen-1-yl)Acetic Acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(7-Methoxynaphthalen-1-yl)acetic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(7-Methoxynaphthalen-1-yl)Acetic Acid Use and application,2-(7-Methoxynaphthalen-1-yl)acetic acid technical grade,usp/ep/jp grade.
Related News: Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).2,6-DIFLUOROBENZOTRIFLUORIDE manufacturer Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).N-Hydroxy-5-norbornene-2,3-dicarboximide supplier Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.(S)-Ethyl-N-Boc-pyroglutamate vendor Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition.Combining its core technological advantages such as ammonia oxidation, phosgenation, and fluorination, the company actively enters the field of fine and functional chemicals, and expands its focus to include polymer additives, replacement of phenolic polymer material monomers, and coating preservatives.
